OTC · Medical - Pharmaceuticals

Noveris Health Sciences Inc. (MYCOF) Stock

$0.80 +0.00% OTC: MYCOF Healthcare

Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products.

Valuation

MetricValue
Price$0.80
Market Cap$46.84M
P/E Ratio-70.00
P/B Ratio-1.42
P/S Ratio0.00
EPS (TTM)$2.37
52-Week High$2.04
52-Week Low$0.03
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE2.04%
ROA-27.51%
ROCE4.01%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.46
Current Ratio0.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-22.0M$-16.0M$-9.0M$-2.0M$-1.0M
Net Profit$-29.0M$-12.0M$-21.0M$-3.0M$3.0M
EPS$-6.17$-1.37$-0.68$-0.05$2.37
Op Margin-294931.0%————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$8.0M$7.0M$0$0$0
Total Liabilities$7.0M$11.0M$12.0M$15.0M$12.0M
Cash$1.0M$0$0$0$0
Borrowings$5.0M$5.0M$5.0M$7.0M$10.0M

Latest News

Noveris Health Sciences Joins BioAlberta TMX Newsfile · Jul 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-24.0M$-8.0M$-4.0M$0$0
Investing Cash Flow$-1.0M$0$1.0M$0$0
Financing Cash Flow$3.0M$0$0$0$0
Net Cash Flow$-1.0M$-1.0M$0$0$0
Free Cash Flow$-24.0M$-8.0M$-4.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.18
EV / EBITDA-924.87
FCF Yield-0.00%
Quick Ratio0.00
Interest Coverage-2.19
Return 1Y220.00%
Return 3Y-87.50%
Return 5Y—

Ownership

Insiders Held0.05%
Institutions Held6.57%
Institutions Float Held6.58%
Institutional HolderSharesReport Date
Hurley Capital, Llc22026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Noveris Health Sciences Inc.

Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013, the company maintains its headquarters in Vancouver, Canada.

Noveris Health Sciences Inc. is headquartered in CA.

Noveris Health Sciences Inc. (MYCOF) stock trades at $0.80 with a market capitalization of $46.84M. The stock is valued at a price-to-earnings (P/E) ratio of -70.00, price-to-book of -1.42, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.03 and $2.04, and currently trades 60.8% below its 52-week high.

On profitability, Noveris Health Sciences Inc. generates a return on equity (ROE) of 2.04%, return on capital employed of 4.01%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: noveris.health

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides